Zimmer Biomet Holdings Inc

ZBH

Equity

ISIN null / Valor 1262932

New York Stock Exchange, Inc (2026-02-23)

USD 99.46+0.72%

Zimmer Biomet Holdings Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Zimmer Biomet Holdings Inc is a global leader in musculoskeletal healthcare, providing a comprehensive range of products and services to help healthcare professionals treat patients suffering from joint disorders and other orthopedic conditions. The company offers a wide variety of innovative solutions, including joint replacement implants, surgical tools, and biologics, to improve patient outcomes and enhance quality of life. With a strong focus on research and development, Zimmer Biomet is dedicated to advancing the field of orthopedics and delivering cutting-edge technologies to meet the evolving needs of healthcare providers and patients worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-5.12%1Y

-19.2%3Y

-32.4%5Y

Performance

32.1%1Y

25.3%3Y

26.4%5Y

Volatility

19460 M

Market cap (USD)

1,532,449

Daily traded volume (Shares)

106.22 / 104.7

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

4.00

Society:

5.00

Nature:

3.00

Federico Ferrari

Switzerland, 18 Oct 2025

Zimmer Biomet is a solid, undervalued orthopedic leader with stable growth and good dividends. Moderate risks and a defensive sector make it attractive for medium- to long-term investments.

EQUITIES OF THE SAME SECTOR

Laboratorios Farmaceuticos Rovi, SA